Blood pressure control in diabetic nephropathy

被引:0
|
作者
Katayama, S [1 ]
机构
[1] Saitama Med Sch, Dept Med 4, Moroyamacho, Saitama 3500494, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:113 / 119
页数:7
相关论文
共 50 条
  • [41] GLYCAEMIC CONTROL INFLUENCES SHORT-TERM BLOOD PRESSURE VARIABILITY IN TYPE 2 DIABETIC PATIENTS WITH OVERT DIABETIC NEPHROPATHY
    Liu, Fang
    Wu, Min
    Fu, Ping
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 92 - 92
  • [42] Salt sensitive blood pressure - An intermediate phenotype predisposing to diabetic nephropathy?
    Strojek, K
    Ferrari, P
    Grzeszczak, W
    Ritz, E
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 329A - 329A
  • [43] Prognostic importance of home blood pressure measurement in patients with diabetic nephropathy
    Nishimura M.
    Kato M.
    Shimada F.
    Kato Y.
    Todo R.
    Ando Y.
    Hida K.
    Iseda I.
    Tone A.
    Nagase N.
    Yoshizumi H.
    Higashi K.
    Hoshiyama Y.
    Diabetology International, 2011, 2 (1) : 10 - 18
  • [44] HIGH-NORMAL BLOOD-PRESSURE AND EARLY DIABETIC NEPHROPATHY
    CHASE, HP
    GARG, SK
    HARRIS, S
    HOOPS, SL
    MARSHALL, G
    ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (03) : 639 - 641
  • [45] Aliskiren Reduces Morning Blood Pressure in Hypertensive Patients with Diabetic Nephropathy
    Takenaka, Tsuneo
    Nobe, Kanako
    Okayama, Mika
    Kojima, Eriko
    Nodaira, Yuka
    Sueyoshi, Keita
    Hoshi, Hitoshi
    Watanabe, Yusuke
    Takane, Hiroshi
    Suzuki, Hiromichi
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2012, 34 (04) : 243 - 248
  • [46] Optimal dose of losartan for renoprotection and blood pressure reduction in diabetic nephropathy
    Andersen, S
    Rossing, P
    Juhl, TR
    Parving, HH
    DIABETOLOGIA, 2000, 43 : A261 - A261
  • [47] Individualized blood pressure targets in Asian diabetic patients with or without nephropathy
    Chan, Juliana C. N.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S12 - S12
  • [48] ACHIEVING BLOOD PRESSURE GOALS IN HIGH RISK PATIENTS WITH DIABETIC NEPHROPATHY
    Van Buren, P. N.
    Adams-Huet, B.
    Toto, R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2010, 58 (02) : 432 - 432
  • [49] Tight blood glycaemic and blood pressure control in experimental diabetic nephropathy reduces extracellular matrix production without regression of fibrosis
    Conway, Bryan R.
    Betz, Boris
    Sheldrake, Tara A.
    Manning, Jonathan R.
    Dunbar, Donald R.
    Dobyns, Abigail
    Hughes, Jeremy
    Mullins, John J.
    NEPHROLOGY, 2014, 19 (12) : 802 - 813
  • [50] Comparison of office blood pressure, self-monitored blood pressure and ambulatory blood pressure in type 2 diabetes with diabetic nephropathy
    Lou, LM
    Gimeno, JA
    Sánchez, RG
    Labrador, T
    Beguer, P
    Lou, MT
    Boned, B
    Aguilar, E
    NEFROLOGIA, 2002, 22 (02): : 179 - 189